MLC901 significantly improved post-concussion symptoms, quality of life, and mood at 6 and 9 months. 2. MLC901 was safe and well tolerated with high adherence and no serious adverse events. 3. MLC901 ...

In this pilot cohort study, a multi-system hospital-based violence intervention program in the St. Louis region did not ...

Among adult patients with migraine headaches, the use of a prescribed digital health app did not reduce the number of ...

In this randomized controlled trial, weekly administration of Mazdutide resulted in significant weight reduction in adults ...

In this randomized controlled trial, vaporized nicotine products were associated with higher rates of smoking abstinence compared with nicotine gum and lozenges among people with low socioeconomic ...

In this cross-sectional study, a new obesity framework from the European Association for the Study of Obesity reclassified an ...

In elderly patients 65 years of age or older with heart failure with reduced ejection fraction (HFrEF), regular use of sodium ...

In acute myocardial infarction (AMI) survivors younger than the age of 65, living in a marginalized neighbourhood was ...

In this population-based cohort study, patients with type 2 diabetes who received glucagon-like peptide-1 receptor agonists had a higher risk of developing gastroesophageal reflux disease and ...

In this randomized trial, among patients with idiopathic pulmonary fibrosis (IPF), nerandomilast slowed the decline in the ...